Search results
Perrigo agrees to sell rare disease unit to Esteve for €275 million By Investing.com
Investing.com· 7 days agoPharma Works Council in France and customary closing conditions, including regulatory approvals....
Central Banks Are Wrong about Rate Cuts
Ludwig von Mises Institute· 5 days agoWhen we talk about monetary policy, people do not understand the importance of interest rates reflecting the reality of inflation and risk. Interest...
888 Holdings Reportedly Facing £100m Bill following Legal Battle
Covers.com· 7 days agoRegulatory pressure is looming for 888 Holdings, the parent company of internationally renowned...
FTSE 100 live: Shares jump to new record high as HSBC and Whitbread rise
Proactive Investors· 2 days agoThe Financial Conduct Authority (FCA) is getting more pushback over its plans to 'name and shame'...
Azora Acquires Two Urban Hostels in Dublin and Barcelona
Hospitality Net· 3 days agoThe two unencumbered urban hostels, Jacobs Inn Dublin and Jacobs Inn Barcelona, add a combined 85...
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275...
WJTV Jackson· 7 days agoPerrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that pharmaceutical company Esteve Healthcare, S.L. ("ESTEVE" ...